7.13

3.65% -0.27

After Hours: 7.13

Lifeward Ltd (LFWD)

Overview News Price History Discussions Forecast

Lifeward Ltd stock is traded at $7.13, with a volume of 2,431. It is down -3.65% in the last 24 hours and down -7.52% over the past month. Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.

Previous Close:

$7.40

Open:

$7.12

24h Volume:

2,431

Relative Volume:

0.26

Market Cap:

$20.19M

Revenue:

$20.92M

Net Income/Loss:

$-25.87M

P/E Ratio:

-0.3623

EPS:

-19.6815

Net Cash Flow:

$-15.02M

1W Performance:

+0.42%

1M Performance:

-7.52%

6M Performance:

+12.28%

1Y Performance:

+6.12%

1-Day Range:

$7.12

$7.15

1-Week Range:

$6.98

$7.40

52-Week Range:

$4.14

$10.56

Lifeward Ltd Stock (LFWD) Company Profile

Name

Lifeward Ltd

Sector

Healthcare (1069)

Industry

Medical Devices (140)

Phone

15082511154

Address

2 CABOT ROAD, HUDSON

Employee

Twitter

Next Earnings Date

2026-08-14

Latest SEC Filings

LFWD's Discussions on Twitter

Compare LFWD vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LFWD Lifeward Ltd	7.13	20.96M	20.92M	-25.87M	-15.02M	-19.68
ABT Abbott Laboratories	103.36	182.09B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	91.62	117.54B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	270.01	105.63B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.10	65.16B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.77	49.67B	6.30B	1.07B	1.09B	1.8406

Lifeward Ltd Stock (LFWD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-10-25	Initiated	Laidlaw	Buy
Apr-03-17	Downgrade	Barclays	Equal Weight → Underweight
Dec-16-16	Initiated	Oppenheimer	Outperform
Jul-15-16	Initiated	Piper Jaffray	Overweight
May-22-15	Upgrade	Canaccord Genuity	Hold → Buy
May-08-15	Reiterated	Barclays	Equal Weight
Oct-07-14	Initiated	Barclays	Equal Weight

View All

Lifeward Ltd Stock (LFWD) Latest News

Sep 10, 2026

Lifeward posts investor presentation outlining commercial progress, $21.8M LTM revenue and Oramed-funded partnership - TradingView

Sep 08, 2026

Oramed backs exoskeleton maker Lifeward (NASDAQ: LFWD) in milestone-based funding deal - Stock Titan

Sep 08, 2026

Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy - Yahoo Finance

Sep 08, 2026

Sep 01, 2026

Lifeward Announces Major CEO and CFO Leadership Changes - The Globe and Mail

Sep 01, 2026

Aug 31, 2026

Lifeward names Josh Hexter interim CEO, Rami Aviram as CFO By Investing.com - Investing.com Canada

Aug 31, 2026

LFWD Looks 11.8% Overvalued on GF Value™ - GuruFocus

Aug 31, 2026

Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer - The Manila Times

Aug 31, 2026

Lifeward (NASDAQ: LFWD) CEO departs as board taps interim chief - Stock Titan

Aug 31, 2026

Lifeward Ltd Announces CEO Changes - marketscreener.com

Aug 31, 2026

Lifeward Ltd Announces Appointment of Rami Aviram as Chief Financial Officer, Effective November 1, 2026 - marketscreener.com

Aug 31, 2026

Aug 28, 2026